Reassessing the current TNM lymph node staging for renal cell carcinoma.

  title={Reassessing the current TNM lymph node staging for renal cell carcinoma.},
  author={Carlo Terrone and Cecilia Maria Cracco and Francesco Porpiglia and Enrico Bollito and Cesare Marco Scoffone and Massimiliano Poggio and Alfredo Berruti and Francesca Ragni and Marco Cossu and Roberto Mario Scarpa and Salvatore Rocca Rossetti},
  journal={European urology},
  volume={49 2},
OBJECTIVE The most commonly used staging system for renal cell carcinoma (RCC) is the tumor-node-metastasis (TNM) system. In the most recent TNM edition, lymph node (LN) involvement is defined as pN0, pN1, or pN2, depending on the number of metastatic LNs (none, 1, or >1). This study evaluated the prognostic value of this classification and tried to improve its clinical impact by considering an additional parameter, that is, LN density (ratio between number of positive LNs and total number of… CONTINUE READING